Avricore Health (AVCRF) Convertible Debt (2011 - 2014)

Avricore Health (AVCRF) posted quarterly Convertible Debt of $15163.7 for Q3 2014, down 49.83% quarter-over-quarter from $30225.9 in Q2 2014.

Avricore Health (AVCRF) Convertible Debt (2011 - 2014) Analysis & Trends

Avricore Health (AVCRF) has reported Convertible Debt for 1 consecutive years, with $15163.7 the latest figure, recorded in Q3 2014.

In Q3 2014, Convertible Debt changed N/A year-over-year to $15163.7; the TTM figure through Sep 2014 stood at $15163.7 (changed N/A YoY), while the FY2014 annual figure was $30840.1, changed N/A from the prior year.
Convertible Debt fell to $15163.7 in Q3 2014 per AVCRF's latest filing, from $30225.9 in the prior quarter.
Across five years, Convertible Debt topped out at $30225.9 in Q2 2014 and bottomed at $15163.7 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Avricore Health	3.04 Mn	3.01 Mn	-6.20 Bn

Download Data